Mark Sculpher : Citation Profile

Are you Mark Sculpher?

12

H index

15

i10 index

820

Citations

RESEARCH PRODUCTION:

19

Articles

18

Papers

2

Books

2

Chapters

RESEARCH ACTIVITY:

   22 years (1995 - 2017). See details.
   Cites by year: 37
   Journals where Mark Sculpher has often published
   Relations with other researchers
   Recent citing documents: 47.    Total self citations: 20 (2.38 %)

MORE DETAILS IN:
ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/psc810
   Updated: 2024-11-06    RAS profile: 2023-03-11    
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers

Works with:

Authors registered in RePEc who have co-authored more than one work in the last five years with Mark Sculpher.

Is cited by:

Brouwer, Werner (32)

Claxton, Karl (22)

Walker, Simon (19)

Asaria, Miqdad (12)

van Exel, Job (9)

Russell, Louise (8)

Revill, Paul (8)

Soares, Marta (7)

EPSTEIN, DAVID (6)

Aas, Eline (6)

Culyer, Anthony (6)

Cites to:

Claxton, Karl (50)

Culyer, Anthony (17)

Brouwer, Werner (17)

Johannesson, Magnus (14)

Rice, Nigel (12)

McCabe, Christopher (9)

Walker, Simon (8)

Aldy, Joseph (6)

Mullahy, John (6)

Devlin, Nancy (6)

van Exel, Job (5)

Main data

Where Mark Sculpher has published?

Journals with more than one article published# docs
PharmacoEconomics8
Health Economics6
The European Journal of Health Economics2

Working Papers Series with more than one paper published# docs
Working Papers / Centre for Health Economics, University of York13
Centre for Health Economics and Policy Analysis Working Paper Series / Centre for Health Economics and Policy Analysis (CHEPA), McMaster University, Hamilton, Canada3

Recent works citing Mark Sculpher (2024 and 2023)

YearTitle of citing document
2023Structural cumulative survival models for estimation of treatment effects accounting for treatment switching in randomized experiments. (2023). Tchetgen, Eric J ; Ying, Andrew. In: Biometrics. RePEc:bla:biomet:v:79:y:2023:i:3:p:1597-1609.

Full description at Econpapers || Download paper

2023The long process by which HTA became a paradigm: A longitudinal conceptual structure analysis. (2023). Cuccurullo, Corrado ; Lavorato, Domenica ; Scaletti, Alessandro ; Belfiore, Alessandra. In: Health Policy. RePEc:eee:hepoli:v:127:y:2023:i:c:p:74-79.

Full description at Econpapers || Download paper

2023The impact of different types of NHS expenditure on health: Marginal cost per QALY estimates for England for 2016/17. (2023). Claxton, Karl ; Martin, Stephen ; Longo, Francesco ; Lomas, James. In: Health Policy. RePEc:eee:hepoli:v:132:y:2023:i:c:s0168851023000854.

Full description at Econpapers || Download paper

2024Economic Evaluations of Obesity-Targeted Sugar-Sweetened Beverage (SSB) Taxes–A Review to Identify Methodological Issues. (2024). Khoo, Terence ; Cronin, Paula ; de Abreu, Richard ; Thiboonboon, Kittiphong ; Goodall, Stephen. In: Health Policy. RePEc:eee:hepoli:v:144:y:2024:i:c:s0168851024000861.

Full description at Econpapers || Download paper

2023How to forecast mental healthcare needs? Distinguishing between perceived and unperceived needs and their impact on capacity requirements. (2023). Cardoso-Grilo, Teresa ; Kalakou, Sofia ; Gouveia, Catarina. In: Socio-Economic Planning Sciences. RePEc:eee:soceps:v:87:y:2023:i:pa:s0038012123000526.

Full description at Econpapers || Download paper

2024Competition, value-based prices and incentives to research personalised drugs. (2024). Levaggi, Rosella. In: Socio-Economic Planning Sciences. RePEc:eee:soceps:v:93:y:2024:i:c:s0038012124000697.

Full description at Econpapers || Download paper

2023A structured methodology for essential medicines lists and health emergency stockpiles: Experience with the Emergency Medicines Buffer Stock in the United Kingdom. (2023). Kanavos, P ; Montibeller, G ; Angelis, A. In: Social Science & Medicine. RePEc:eee:socmed:v:337:y:2023:i:c:s0277953623005932.

Full description at Econpapers || Download paper

2024Economic costs of perinatal depression and anxiety in a lower-middle income country: Pakistan. (2024). Husain, Nusrat ; Wagas, Ahmed ; Tayyaba, Kiran ; Sikander, Siham ; Malik, Abid ; Gregoire, Alain ; Chaudhry, Nasim ; Alvi, Mohsin ; Knapp, Martin ; Bauer, Annette. In: LSE Research Online Documents on Economics. RePEc:ehl:lserod:122650.

Full description at Econpapers || Download paper

2023Transmission modeling to infer tuberculosis incidence prevalence and mortality in settings with generalized HIV epidemics. (2023). Cohen, Ted ; MacPherson, Peter ; Hayes, Richard J ; Pretorius, Carel ; Glaziou, Philippe ; Ku, Chu-Chang ; Shaweno, Debebe ; Dodd, Peter J ; Ayles, Helen. In: Nature Communications. RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-37314-1.

Full description at Econpapers || Download paper

2023ShinyPrior: A tool for estimating probability distributions using published evidence. (2023). Blythe, Robin ; White, Nicole. In: OSF Preprints. RePEc:osf:osfxxx:zf62e.

Full description at Econpapers || Download paper

2023Constructing Relative Effect Priors for Research Prioritization and Trial Design: A Meta-epidemiological Analysis. (2023). Welton, Nicky J ; Jankovic, Dina ; Nikolaidis, Georgios ; Glynn, David. In: Medical Decision Making. RePEc:sae:medema:v:43:y:2023:i:5:p:553-563.

Full description at Econpapers || Download paper

2023General-Purpose Methods for Simulating Survival Data for Expected Value of Sample Information Calculations. (2023). Wislff, Torbjrn ; Welton, Nicky J ; Strong, Mark ; Claxton, Karl P ; Aas, Eline ; Vervaart, Mathyn ; Heath, Anna. In: Medical Decision Making. RePEc:sae:medema:v:43:y:2023:i:5:p:595-609.

Full description at Econpapers || Download paper

2023Closed-Form Solution of the Unit Normal Loss Integral in 2 Dimensions, with Application in Value-of-Information Analysis. (2023). Sadatsafavi, Mohsen ; Gustafson, Paul ; Lee, Tae Yoon. In: Medical Decision Making. RePEc:sae:medema:v:43:y:2023:i:5:p:621-626.

Full description at Econpapers || Download paper

2023Pricing Treatments Cost-Effectively when They Have Multiple Indications: Not Just a Simple Threshold Analysis. (2023). Cipriano, Lauren E ; Goldhaber-Fiebert, Jeremy D. In: Medical Decision Making. RePEc:sae:medema:v:43:y:2023:i:7-8:p:914-929.

Full description at Econpapers || Download paper

2023Economic Evaluation of Medically Assisted Reproduction: A Methodological Systematic Review. (2023). Dahooghe, Thomas ; van Muylder, Astrid ; Luyten, Jeroen. In: Medical Decision Making. RePEc:sae:medema:v:43:y:2023:i:7-8:p:973-991.

Full description at Econpapers || Download paper

2023Cost Effectiveness of Allogeneic Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Patients with Knee Osteoarthritis. (2023). Suh, Dong-Churl ; Ha, Gwi-Yeom ; Ku, Myung ; Lim, Hong Chul ; Choi, Hangseok ; Lee, Seung-Mi ; Gomoll, Andreas ; Cole, Brian J. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:21:y:2023:i:1:d:10.1007_s40258-022-00762-9.

Full description at Econpapers || Download paper

2023Economic Evaluation of Evusheld for Preexposure Prevention of COVID-19 in High-Risk Populations: Early Evidence from Thailand. (2023). Iamsirithaworn, Sopon ; Isaranuwatchai, Wanrudee ; Poonsiri, Chittawan ; Rattanavipapong, Waranya ; Teerawattananon, Yot ; Kitphati, Rungrueng ; Sonthichai, Chaninan ; Apakupakul, Jutarat. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:21:y:2023:i:3:d:10.1007_s40258-023-00796-7.

Full description at Econpapers || Download 2023

The Broader Opportunity Costs in the Broader Cost-Effectiveness Analysis Framework. (2023). Vallejo-Torres, Laura. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:21:y:2023:i:3:d:10.1007_s40258-023-00801-z.

Full description at Econpapers || Download paper

2023How Much Should be Invested in Lung Care Across the WHO European Region? Applying a Monetary Value to Disability-Adjusted Life-Years Within the International Respiratory Coalition’s Lung Facts. (2023). Joos, Guy ; Welte, Tobias ; Angus, Colin ; Franklin, Matthew. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:21:y:2023:i:4:d:10.1007_s40258-023-00802-y.

Full description at Econpapers || Download paper

2023Understanding bias in probabilistic analysis in model-based health economic evaluation. (2023). Volodin, Andrei ; Wang, Myra ; Liu, Sichen ; Schaink, Alexis K ; Xie, Xuanqian. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:2:d:10.1007_s10198-022-01472-8.

Full description at Econpapers || Download paper

2023Reducing the basic reproduction number of COVID-19: a model simulation focused on QALYs, hospitalisation, productivity costs and optimal (soft) lockdown. (2023). Robles-Zurita, Jose. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:4:d:10.1007_s10198-022-01500-7.

Full description at Econpapers || Download paper

2023Mapping analysis to predict SF-6D utilities from health outcomes in people with focal epilepsy. (2023). Savic, Natasa ; Thangavelu, Karthinathan ; Alvarez-Baron, Elena ; Oflaherty, Ewa Drogon ; Medjedovic, Jasmina ; Flint, India ; Longworth, Louise ; Meunier, Aurelie. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:7:d:10.1007_s10198-022-01519-w.

Full description at Econpapers || Download paper

2023Extensions of Health Economic Evaluations in R for Microsoft Excel Users: A Tutorial for Incorporating Heterogeneity and Conducting Value of Information Analyses. (2023). Briggs, Andrew ; Lamrock, Felicity ; Green, Nathan ; Williams, Jack ; Naylor, Nichola R. In: PharmacoEconomics. RePEc:spr:pharme:v:41:y:2023:i:1:d:10.1007_s40273-022-01203-0.

Full description at Econpapers || Download paper

2023How is the Societal Perspective Defined in Health Technology Assessment? Guidelines from Around the Globe. (2023). Lorgelly, Paula ; Yang, Xiaozhe ; Avar, Tuba Saygin. In: PharmacoEconomics. RePEc:spr:pharme:v:41:y:2023:i:2:d:10.1007_s40273-022-01221-y.

Full description at Econpapers || Download paper

2023Comprehensive Review of Methods to Assess Uncertainty in Health Economic Evaluations. (2023). Joore, Manuela A ; Ramaekers, Bram ; Grimm, Sabine E ; Otten, Thomas Michael. In: PharmacoEconomics. RePEc:spr:pharme:v:41:y:2023:i:6:d:10.1007_s40273-023-01242-1.

Full description at Econpapers || Download paper

2023Cost Effectiveness of CDK4/6 Inhibitors in the First-Line Treatment of HR+/HER2? Metastatic Breast Cancer in Postmenopausal Women in the USA. (2023). Trivedi, Meghana V ; Deshmukh, Ashish A ; Damgacioglu, Haluk ; Masurkar, Prajakta P. In: PharmacoEconomics. RePEc:spr:pharme:v:41:y:2023:i:6:d:10.1007_s40273-023-01245-y.

Full description at Econpapers || Download paper

2023The Value of Health in a Cost-Effectiveness Analysis: Theory Versus Practice. (2023). Brouwer, Werner ; Versteegh, Matthijs ; Baal, Pieter ; Wouterse, Bram. In: PharmacoEconomics. RePEc:spr:pharme:v:41:y:2023:i:6:d:10.1007_s40273-023-01265-8.

Full description at Econpapers || Download paper

2023Cost-Effectiveness of Sequential Abaloparatide/Alendronate in Men at High Risk of Fractures in the United States. (2023). Reginster, Jean-Yves ; Caminis, John ; Wang, Yamei ; Mathew, Jake ; Pearman, Leny ; Singer, Andrea J ; Silverman, Stuart S ; Hiligsmann, Mickael. In: PharmacoEconomics. RePEc:spr:pharme:v:41:y:2023:i:7:d:10.1007_s40273-023-01270-x.

Full description at Econpapers || Download paper

2023Evaluation of Cost-Effectiveness of Adjuvant Osimertinib in Patients with Resected EGFR Mutation-Positive Non-small Cell Lung Cancer. (2023). Samson, Benoit ; Moldaver, Daniel ; Melosky, Barbara ; Shaw, Simon ; Cheema, Parneet ; Miranda, Miguel ; Verhoek, Andre ; Bracke, Benjamin ; Dalfsen, Nadia ; Heeg, Bart ; Wu, Yi-Long ; John, Thomas ; Marinis, Filippo ; Shepherd, Frances A. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:7:y:2023:i:3:d:10.1007_s41669-023-00396-0.

Full description at Econpapers || Download 2023

Cost Effectiveness of Strategies for Caring for Critically Ill Patients with COVID-19 in Tanzania. (2023). Baker, Peter ; Barasa, Edwine ; Were, Vincent ; Kairu, Angela ; Khalid, Karima ; Awadh, Khamis ; Kuwawenaruwa, August ; Schell, Carl Otto ; Shah, Hiral Anil ; Guinness, Lorna. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:7:y:2023:i:4:d:10.1007_s41669-023-00418-x.

Full description at Econpapers || Download paper

2023Cost-Effectiveness Analysis of Antimicrobial Prescribing in the Treatment of Clostridioides Difficile Infection in England. (2023). Pink, Joshua ; Woods, Sam ; Coote, Laura ; Holmes, Hayden ; Bromilow, Tom. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:7:y:2023:i:5:d:10.1007_s41669-023-00420-3.

Full description at Econpapers || Download paper

2023Partially different? The importance of general equilibrium in health economic evaluations: An application to nocturia. (2023). Yerushalmi, Erez ; Burtea, Teodor ; Andersson, Fredrik L ; Hafner, Marco. In: Health Economics. RePEc:wly:hlthec:v:32:y:2023:i:3:p:654-674.

Full description at Econpapers || Download paper

2024Achieving dynamic efficiency in pharmaceutical innovation: Identifying the optimal share of value and payments required. (2024). Sculpher, Mark ; Lomas, James ; Woods, Beth ; Claxton, Karl ; Weatherly, Helen. In: Health Economics. RePEc:wly:hlthec:v:33:y:2024:i:4:p:804-819.

Full description at Econpapers || Download paper

Works by Mark Sculpher:

YearTitleTypeCited
2015Country-level cost-effectiveness thresholds: initial estimates and the need for further research In: Working Papers.
[Full Text][Citation analysis]		paper51
2016Supporting the development of an essential health package: principles and initial assessment for Malawi In: Working Papers.
[Full Text][Citation analysis]		paper3
2017Scoping review on social care economic evaluation methods In: Working Papers.
[Full Text][Citation analysis]		paper0
1999A critical structured review of economic evaluations of interventions for the prevention and treatment of osteoporosis In: Working Papers.
[Full Text][Citation analysis]		paper0
2000Improving the efficiency and relevance of health technology assessent: the role of iterative decision analytic modelling In: Working Papers.
[Full Text][Citation analysis]		paper7
2007Mark versus Luke? Appropriate Methods for the Evaluation of Public Health Interventions In: Working Papers.
[Full Text][Citation analysis]		paper12
2010Appropriate Perspectives for Health Care Decisions In: Working Papers.
[Full Text][Citation analysis]		paper42
2005The value of implementation and the value of information: combined and uneven development In: Working Papers.
[Full Text][Citation analysis]		paper3
2011Value-based pricing for pharmaceuticals: Its role, specification and prospects in a newly devolved NHS In: Working Papers.
[Full Text][Citation analysis]		paper11
2012Coverage with evidence development, only in research, risk sharing or patient access scheme? A framework for coverage decisions In: Working Papers.
[Full Text][Citation analysis]		paper25
2013Methods for the estimation of the NICE cost effectiveness threshold In: Working Papers.
[Full Text][Citation analysis]		paper48
2014Using cost-effectiveness thresholds to determine value for money in low- and middle-income country healthcare systems: Are current international norms fit for purpose? In: Working Papers.
[Full Text][Citation analysis]		paper8
2006Defining and characterising structural uncertainty in decision analytic models In: Working Papers.
[Full Text][Citation analysis]		paper6
2009Methods for assessing the cost-effectiveness of public health interventions: Key challenges and recommendations In: Health Policy.
[Full Text][Citation analysis]		article29
2002Shared treatment decision making in a collectively funded health care system: possible conflicts and some potential solutions In: Social Science & Medicine.
[Full Text][Citation analysis]		article4
2012Decision-making with Uncertainty: The Value of Information In: Chapters.
[Full Text][Citation analysis]		chapter0
2006Decision-making with Uncertainty: The Value of Information.(2006) In: Chapters.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 0		chapter
1999Recognizing Preference Diversity: The Use of Preference Sub-Groups in Cost-Effectiveness Analysis In: Centre for Health Economics and Policy Analysis Working Paper Series.
[Full Text][Citation analysis]		paper0
1999Income Effects of Reduced Health and Health Effects of Reduced Income: Implications for Health State Valuation In: Centre for Health Economics and Policy Analysis Working Paper Series.
[Full Text][Citation analysis]		paper0
1999Building Uncertainty into Cost-Effectiveness Rankings: Portfolio Risk-Return Trade-Offs and Implications for Decision Rules In: Centre for Health Economics and Policy Analysis Working Paper Series.
[Full Text][Citation analysis]		paper0
2000Productivity Costs: Principles and Practice in Economic Evaluation In: Monograph.
[Full Text][Citation analysis]		book13
2006Decision Modelling for Health Economic Evaluation In: OUP Catalogue.
[Citation analysis]		book382
2014What is the Quality of Economic Evaluations of Non-Drug Therapies? A Systematic Review and Critical Appraisal of Economic Evaluations of Radiotherapy for Cancer In: Applied Health Economics and Health Policy.
[Full Text][Citation analysis]		article0
2010An economic model for the prevention of MRSA infections after surgery: non-glycopeptide or glycopeptide antibiotic prophylaxis? In: The European Journal of Health Economics.
[Full Text][Citation analysis]		article0
2005Estimating utility data from clinical indicators for patients with stable angina In: The European Journal of Health Economics.
[Full Text][Citation analysis]		article7
2000Costs Incurred by Patients Undergoing Advanced Colorectal Cancer Therapy In: PharmacoEconomics.
[Full Text][Citation analysis]		article1
2006Assessing Generalisability in Model-Based Economic Evaluation Studies In: PharmacoEconomics.
[Full Text][Citation analysis]		article3
2007A Comparison of the Cost Effectiveness of Pharmacotherapy or Surgery (Laparoscopic Fundoplication) in the Treatment of GORD In: PharmacoEconomics.
[Full Text][Citation analysis]		article0
2007Recombinant Erythropoietin for Chemotherapy-Related Anaemia In: PharmacoEconomics.
[Full Text][Citation analysis]		article3
2012Real Economics Needs to Reflect Real Decisions In: PharmacoEconomics.
[Full Text][Citation analysis]		article3
2012Golimumab for the Treatment of Psoriatic Arthritis In: PharmacoEconomics.
[Full Text][Citation analysis]		article26
2013Acknowledging Patient Heterogeneity in Economic Evaluation In: PharmacoEconomics.
[Full Text][Citation analysis]		article2
2016Should the Lambda (?) Remain Silent? In: PharmacoEconomics.
[Full Text][Citation analysis]		article0
2005Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra In: Health Economics.
[Full Text][Citation analysis]		article68
2006Evidence synthesis, parameter correlation and probabilistic sensitivity analysis In: Health Economics.
[Full Text][Citation analysis]		article11
2010Sins of omission and obfuscation: IQWIGs guidelines on economic evaluation methods In: Health Economics.
[Full Text][Citation analysis]		article2
2011Dangerous omissions: the consequences of ignoring decision uncertainty In: Health Economics.
[Full Text][Citation analysis]		article11
2015CAUSES FOR CONCERN: IS NICE FAILING TO UPHOLD ITS RESPONSIBILITIES TO ALL NHS PATIENTS? In: Health Economics.
[Full Text][Citation analysis]		article24
1995Sensitivity analysis in economic evaluation: A review of published studies In: Health Economics.
[Full Text][Citation analysis]		article13
1995Economic Evaluation in Health Care Research and Development: Undertake it Early and Often In: Discussion Papers.
[Full Text][Citation analysis]		paper2
1996Antenatal testing for HIV Infection: Developing a Model for Economic Evaluation In: Discussion Papers.
[Full Text][Citation analysis]		paper0

CitEc is a RePEc service, providing citation data for Economics since 2001. Last updated November, 3 2024. Contact: CitEc Team